John Krumme, MD
Orthopaedic Surgery · Albuquerque, NMNPI 1689092520
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,778 of the $9,604 with a category attached, or 60.2%. Stryker accounts for 60.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $3,381 and has fallen 65.4% since, to $1,170 in 2025.
Across 142 payments — averaging $67.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Smith+Nephew$2K
- Zimmer Biomet$2K
- BD$164
- Johnson & Johnson$125
- Onkos Surgical, Inc.$123
- plus $122 from 2 others
What the payments were for
- Travel & lodging$3,82640%
- Food & beverage$5,77860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 98 | $5,818 |
| Smith+Nephew | 14 | $1,630 |
| Zimmer Biomet | 22 | $1,622 |
| BD | 1 | $164 |
| Johnson & Johnson | 2 | $125 |
| Onkos Surgical, Inc. | 3 | $123 |
| Bone Support Inc. | 1 | $99 |
| Illuminoss Medical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,063
- Legion$1,005
- TRIGEN InterTAN$783
- VISIONAIRE$783
- Persona$493
- REDAPT$359
- INSIGNIA$311
- OR3O Dual Mobility$222
- Tandem$222
- Actishield$170
- ARISTA AH FLEXITIP$164
- Taperloc$163
- NA$158
- AEQUALIS$153
- G7$142
- T2$131
- ATTUNE$101
How this compares
$9,604 in reported general payments places this provider in the 75th percentile of 107 orthopaedic surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 208 | $6,909 |
| Meloxicam | 686 | $1,854 |
| Oxycodone Hcl | 156 | $756 |
| Gabapentin | 24 | $559 |
| Amoxicillin | 157 | $480 |
| Cephalexin | 41 | $447 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $265 |
| Tramadol Hcl | 45 | $164 |
| Clindamycin Hcl | 23 | $142 |
| Cyclobenzaprine Hcl | 30 | $111 |
| Methylprednisolone | 17 | $110 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Albuquerque
- Deana MercerAlbuquerque$901K
- David ChafeyAlbuquerque$108K
- Heather MenzerAlbuquerque$61K
- Ernesto Otero LopezAlbuquerque$50K
- Rick GehlertAlbuquerque$46K
- Jeffrey BeckenbaughAlbuquerque$46K
- Matthew WhartonAlbuquerque$22K
- Jeffrey RaccaAlbuquerque$20K
- Michael ArchibeckAlbuquerque$19K
- Samer KakishAlbuquerque$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.